.png)
.png)
Paradromics Announces Neurotech Track at Built with Biology 2022
AUSTIN, TX – Paradromics Inc., an Austin-based medical technology company, today announced participation in the 2022 Built with Biology Global Synthetic Biology conference, April 12-14 in Oakland, California. (Built with Biology was formerly known as SynBioBeta.) This year’s conference features a day of neurotechnology programming on April 12, which was organized in cooperation with Paradromics.
Paradromics CEO and Founder, Matt Angle, PhD, is moderating a panel entitled “Can Neurotech Transform Mental Health?” featuring panelists Renee Ryan, CEO of Cala Health, Brian Pepin, CEO of Rune Labs, and Juan-Pablo Mas, Partner, at Action Potential VC. Dr. Angle is a panelist for the session titled “Engineering the Mind”, a fireside chat that will explore the vast potential and implications of neurotechnology.
Find Paradromics in the Exhibit hall in booth #19, and see the full schedule details here.
[UPDATE 4/22/2022] Clips from the main stage panel moderated by futurist Ramez Naam and featuring Blackrock Creative Director Taryn Southern, Paradromics founder and CEO Matt Angle, and Prime Movers Lab General Partner, Amy Kruse are now available.
%20(1).svg)
Paradromics Accepted to FDA Regulatory Accelerator Program and Announces New Patient Registry
Paradromics CEO Matt Angle on the Neuralink Demo
Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA
The Neurotech Revolution goes (back) to Washington!
.svg)